ARTICLE | Company News

GSK staying put with established products

December 6, 2014 3:39 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) dropped its plan to divest a portfolio of U.S. and European established products after evaluating bids from potential buyers. GSK spokesperson Melinda Stubbee declined to provide further details.

In July, the company said it expected to close a deal by year end for a portfolio of established products that had combined sales of about L1 billion ($1.7 billion). ...